Deka Bank Deutsche Girozentrale Igm Biosciences, Inc. Transaction History

Deka Bank Deutsche Girozentrale

  • $53.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$6.66 - $10.64 $41,977 - $67,063
6,303 New
6,303 $50,000
Q1 2022

Apr 28, 2022
BUY
$13.42 - $29.73 $10,736 - $23,784
800 Added 9.64%
9,100 $235,000
Q4 2021

Feb 02, 2022
BUY
$27.59 - $66.39 $5,518 - $13,278
200 Added 2.47%
8,300 $241,000
Q4 2020

Mar 12, 2021
BUY
$47.41 - $115.03 $384,021 - $931,743
8,100 New
8,100 $707,000

Others Institutions Holding IGMS

# of Institutions
89
Shares Held
21.4M
Call Options Held
39.5K
Put Options Held
16.5K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email